Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema

References

• AgostoniAAygören-PürsünEBinkleyKEHereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyondJ Allergy Clin Immunol20041143 SupplS51S13115356535
   PubMed Web of Science ®Google Scholar
• BorkKMengGStaubachPHardtJHereditary angioedema: new findings concerning symptoms, affected organs, and courseAm J Med2006119326727416490473
   PubMed Web of Science ®Google Scholar
• BygumAHereditary angio-oedema in Denmark: a nationwide surveyBr J Dermatol200916151153115819709101
   PubMed Web of Science ®Google Scholar
• CaballeroTBaezaMLCabanasRSpanish Study Group on Bradykinin-Induced AngioedemaGrupo Español de Estudio del Angioedema mediado por BradicininaConsensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosisJ Investig Allergol Clin Immunol2011215333347 quiz follow 347
   PubMed Web of Science ®Google Scholar
• RocheOBlanchACaballeroTSastreNCallejoDLopez-TrascasaMHereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in SpainAnn Allergy Asthma Immunol200594449850315875532
   PubMed Web of Science ®Google Scholar
• FrankMMGelfandJAAtkinsonJPHereditary angioedema: the clinical syndrome and its managementAnn Intern Med19768455805931275365
   PubMed Web of Science ®Google Scholar
• BorkKHardtJSchicketanzKHResselNClinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiencyArch Intern Med2003163101229123512767961
   PubMedGoogle Scholar
• BorkKHardtJWitzkeGFatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiencyJ Allergy Clin Immunol2012130369269722841766
   PubMed Web of Science ®Google Scholar
• GowerRGLumryWRDavis-LortonMAJohnstonDTBussePJCurrent options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerationsAllergy Asthma Proc201233323524022584192
   PubMed Web of Science ®Google Scholar
• CicardiMAgostoniAHereditary angioedemaN Engl J Med199633425166616678628365
   PubMed Web of Science ®Google Scholar
• Aygören-PürsünEBygumABeusterienKSocioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in EuropeOrphanet J Rare Dis201499924996814
   PubMed Web of Science ®Google Scholar
• ZurawBLClinical practice. Hereditary angioedemaN Engl J Med2008359101027103618768946
   PubMed Web of Science ®Google Scholar
• BowenTCicardiMFarkasH2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedemaAllergy Asthma Clin Immunol2010612420667127
   PubMedGoogle Scholar
• CicardiMBorkKCaballeroTHAWK (Hereditary Angioedema International Working Group)Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working GroupAllergy201267214715722126399
   PubMed Web of Science ®Google Scholar
• CraigTAygören-PürsünEBorkKWAO guideline for the management of hereditary angioedemaWorld Allergy Organ J201251218219923282420
   PubMedGoogle Scholar
• BygumAAygören-PürsünECaballeroTThe hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodologyBMC Dermatol201212422536794
   PubMedGoogle Scholar
• CaballeroTAygören-PürsünEBygumAThe humanistic burden of hereditary angioedema: results from the Burden of Illness Study in EuropeAllergy Asthma Proc2014351475324268449
   PubMed Web of Science ®Google Scholar
• TolleyKWhat Are Health Utilities?2nd edLondonHayward Medical Communications2009
   Google Scholar
• DolanPModeling valuations for EuroQol health statesMed Care19973511109511089366889
   PubMed Web of Science ®Google Scholar
• DrummondMFIglesiasCPCooperNJSystematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellence in the United Kingdom: a game of two halves?Int J Technol Assess Health Care200824214615018400116
   PubMed Web of Science ®Google Scholar
• PhillipsCWhat Is a QALY?2nd edLondonHayward Medical Communications2009
   Google Scholar
• WilsonDABorkKSheaEPRentzAMBlausteinMBPullmanWEEconomic costs associated with acute attacks and long-term management of hereditary angioedemaAnn Allergy Asthma Immunol2010104431432020408341
   PubMed Web of Science ®Google Scholar
• BygumAAygören-PürsünEBeusterienKBurden of illness in hereditary angioedema: a conceptual modelActa Derm Venereol201595670671025394853
   PubMed Web of Science ®Google Scholar
• EuroQol GroupWhat Is EQ-5D2013 Available from: http://www.euroqol.org/about-eq-5d.htmlAccessed September 19, 2014
   Google Scholar
• SullivanPWSlejkoJFSculpherMJGhushchyanVCatalogue of EQ-5D scores for the United KingdomMed Decis Making201131680080421422468
   PubMed Web of Science ®Google Scholar
• DolanPGudexCKindPWilliamsAA social tariff for EuroQol: Results from a UK general population surveyThe University of York Centre for Health Economics1995 Discussion Paper 1381995 Available from: http://www.york.ac.uk/che/pdf/DP138.pdfAccessed May 10, 2016
   Google Scholar
• HelbertMPangFAlvarez-ReyesMPearsonIVWolowaczSDiwakarLA cost-effectiveness comparison of icatibant and C1-esterase inhibitor concentrate for the symptomatic treatment of acute attacks of types I and II hereditary angioedema in the UK setting [abstract]Value Health201215A513
   Web of Science ®Google Scholar
• CottrellSTidenDJayaramNSinaniRBarnesDHereditary angioedema health state utility valuation study from the perspective of a representative sample of the Australian general public [abstract]Value Health201114A324
   Web of Science ®Google Scholar
• NordenfeltPDawsonSWahlgrenCFLindforsAMallbrisLBjorkanderJQuantifying the burden of disease and perceived health state in patients with hereditary angioedema in SwedenAllergy Asthma Proc201435218519024411585
   PubMed Web of Science ®Google Scholar
• KindPHardmanGMacranSUK population norms for EQ-5DUniversity of York Centre for Health Economics1999 Discussion Paper 1721999 Available from: https://www.york.ac.uk/media/che/documents/papers/discussionpapers/CHEDiscussionPaper172.pdfAccessed May 10, 2016
   Google Scholar
• StaffordMRHareendranANg-MakDSInsingaRPXuRStullDEEQ-5D-derived utility values for different levels of migraine severity from a UK sample of migraineursHealth Qual Life Outcomes2012106522691697
   PubMed Web of Science ®Google Scholar
• WesterhuisWZijlmansMFischerKvan AndelJLeijtenFSCoping style and quality of life in patients with epilepsy: a cross-sectional studyJ Neurol20112581374320658245
   PubMed Web of Science ®Google Scholar
• TerzanoCCremonesiGGirbinoGPRISMA (PRospectIve Study on asthMA control) Study Group1-year prospective real life monitoring of asthma control and quality of life in ItalyRespir Res20121311223216798
   PubMed Web of Science ®Google Scholar
• MusturDVesović-PotićVStanisavljevićDIlleTIlleMAssessment of functional disability and quality of life in patients with ankylosing spondylitisSrp Arh Celok Lek200913752452819950760
   PubMed Web of Science ®Google Scholar
• DyerMTGoldsmithKASharplesLSBuxtonMJA review of health utilities using the EQ-5D in studies of cardiovascular diseaseHealth Qual Life Outcomes201081320109189
   PubMed Web of Science ®Google Scholar
• LeeAJMorganCLConwayPCurrieCJCharacterisation and comparison of health-related quality of life for patients with renal failureCurr Med Res Opin200521111777178316307698
   PubMed Web of Science ®Google Scholar
• LongworthLRowenDNICE DSU Technical Support Document 10: The use of mapping methods to estimate health state utility values2011 Available from: http://www.nicedsu.org.ukAccessed May 10, 2016
   Google Scholar
• IsmailKMaissiEThomasSA randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) studyHealth Technol Assess201014221101iiiiv20483060
   PubMed Web of Science ®Google Scholar
• MarraCAEsdaileJMGuhDA comparison of four indirect methods of assessing utility values in rheumatoid arthritisMed Care200442111125113115586840
   PubMed Web of Science ®Google Scholar
• PickardASJohnsonJAFeenyDHShuaibACarriereKCNasserAMAgreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities IndexStroke200435260761214726549
   PubMed Web of Science ®Google Scholar